Eli Lilly and Co
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
Weight loss drugs are being assessed for their ability to treat conditions like dementia and addiction after a landmark study showed that Wegovy helped reduce the risk of heart attacks and strokes. Bloomberg | Bloomberg | Getty Images LONDON — Scientists have begun investigating whether so-called miracle obesity drugs could be used to treat conditions […]
Read More
‘Robot pills’ could one day help patients avoid needles. The stocks are cheap, but risky
Ask most patients if they prefer to receive medicine by swallowing a pill, by injection or infusion, and most will likely opt for the pill. But that’s not always possible for drugs that use delicate molecules that can’t tolerate the physical and chemical conditions in the gastrointestinal tract. That’s where a number of early-stage drug […]
Read More
Medicare wants to cut the price on an Eli Lilly drug. What it means for LLY shares
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | Reuters Drugmakers aren’t the only ones feeling the impact of the weight loss industry gold rush. Retailers with pharmacy businesses, such […]
Read More
This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher
Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the company’s macular degeneration treatment. If you like this story, sign up for Jim Cramer’s Top 10 Morning Thoughts on the Market email newsletter for free. CNBC’s Jim Cramer said on “Squawk on the Street” that Regeneron is […]
Read More
Redwire and Sierra team up to make drugs in space on inflatable habitat’s first mission
An ADSEP with blue PIL-BOXs, hardware which will be delivered to Sierra Space for the LIFE habitat pathfinder mission. Redwire Space infrastructure company Redwire is putting a biotech technology testbed on Sierra Space’s first mission with its inflatable space habitat, establishing a new partnership between the two companies to make drugs in orbit. “It’s an […]
Read More
Here are some of the companies saying weight loss drugs could impact their business
The impact of new weight loss treatments is being felt well beyond the health-care industry . Analysts used the ritual of quarterly earnings calls to probe companies on whether their businesses were being helped — or hampered by — the latest trend. Drugs that mimic gut hormones like glucagon-like peptide-1, or GLP-1, were first used […]
Read More
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images Blockbuster weight loss drugs are priced significantly higher in the U.S. than in other large, high-income countries, according to a new analysis released Thursday. The report […]
Read More
Here’s a rapid-fire update on all 36 stocks in the Club’s portfolio, including 2 recent buys
During the Investing Club’s August Monthly Meeting, Jim Cramer provided his latest thinking on all 36 names in his Charitable Trust. Source
Read More
These are the top 5 performing Club stocks from mid-July to our August Monthly Meeting
Since the CNBC Investing Club’s July Monthly Meeting, the stock market has seesawed up and then down on a slew of quarterly earnings results and inflation data. That’s left Wall Street struggling this month. Here’s a look at the best performers from the Club’s 36 holdings from the market close after the July 12 meeting […]
Read More